DeepWell DTx

DeepWell Digital Therapeutics (DTx) is at the forefront of innovation, merging technology with gaming and media to tackle the global mental health crisis. Our FDA-cleared software development kit (SDK) utilizes vagal nerve stimulation and breath mechanics to enable over-the-counter treatments for stress and hypertension. This groundbreaking approach empowers media creators to transform their content into engaging, scalable, and affordable medical solutions. This groundbreaking technology offers unparalleled opportunities for gaming and media companies. By integrating DeepWell's SDK, developers can shorten their FDA clearance cycles and provide consumers with game-driven, interactive experiences that improve mental and physical health. DeepWell’s SDK stimulates the vagal nerve, reducing stress and activating dopamine release through interactive media. Our approach ensures that gaming mechanics, such as challenges and progression systems, align seamlessly with therapeutic outcomes. Players report mental health benefits, showcasing the technology's impacts. DeepWell DTx is part of NeuFluent. NeuFluent neurotechnology products are dynamic therapy engines and AI-driven data agents that are jointly developed into or integrated within innovative medical devices and technologies. NeuFluent collaborates with companies looking to leverage NeuFluent neurotechnology to expand the possibilities, accelerate commercialization, and scale their own innovations. Together, they innovate and commercialize the most advanced and accessible neurotechnology to solve complex, chronic medical conditions. Join us in harnessing the unique power of gaming and digital therapeutics to create accessible, effective, and enjoyable mental health care at scale.